日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dihydropyrimidine Dehydrogenase-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction

二氢嘧啶脱氢酶指导的5-氟尿嘧啶给药:优先考虑精准给药而非剂量减少

Kallee, Govind; Milano, Gerard; Ciccolini, Joseph

Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens

环保且经济:PD-1和PD-L1抑制剂替代给药方案的经济和环境评价

Karlsson, Leo; Ciccolini, Joseph; Ter Heine, Rob; Centanni, Maddalena

DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World Study

DPD超快代谢者状态与5-氟尿嘧啶治疗疗效:一项真实世界研究

Kallee, Govind; Milano, Gérard; Duffaud, Florence; Dahan, Laetitia; Ciccolini, Joseph

Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing

体重指数影响伊马替尼暴露量:来自治疗药物监测和自适应给药的真实世界证据

Maroselli, Paul; Fanciullino, Raphaelle; Colle, Julien; Farnault, Laure; Roche, Pauline; Venton, Geoffroy; Costello, Régis; Ciccolini, Joseph

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients

预测维奈托克在真实世界患者中的毒性-疗效比

Osanno, Loïc; Brocque, Lucy; Bourguignon, Laurent; Delpech, Carla; Farnault, Laure; Colle, Julien; Roche, Pauline; Chiaroni, Jacques; Izard, Caroline; Costello, Régis; Dacos, Mathilde; Solas, Caroline; Djezzar, Chems; Ciccolini, Joseph; Cluzeau, Thomas; Venton, Geoffroy; Fanciullino, Raphaëlle

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

在肺癌模型中通过重新安排抗VEGF/细胞毒性药物/抗PD-1联合治疗方案来克服免疫耐药性

Sicard, Guillaume; Protzenko, Dorian; Giacometti, Sarah; Barlési, Fabrice; Ciccolini, Joseph; Fanciullino, Raphaelle

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.

胰腺导管腺癌泛素化谱分析揭示了特定的预后和治疗诊断标志物

El Kaoutari Abdessamad, Fraunhoffer Nicolas A, Audebert Stéphane, Camoin Luc, Berthois Yolande, Gayet Odile, Roques Julie, Bigonnet Martin, Bongrain Claire, Ciccolini Joseph, Iovanna Juan L, Dusetti Nelson J, Soubeyran Philippe

Immune check points in cancer treatment: current challenges and perspectives

癌症治疗中的免疫检查点:当前挑战与展望

Ciccolini, Joseph; Milano, Gerard

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study

一项针对转移性癌症有效患者的非劣效性随机III期试验,比较标准免疫疗法(检查点抑制剂)与降低剂量强度的免疫疗法:MOIO方案研究

Gravis, Gwenaelle; Marino, Patricia; Olive, Daniel; Penault-LLorca, Frederique; Delord, Jean-Pierre; Simon, Clotilde; Lamrani-Ghaouti, Assia; Sabatier, Renaud; Ciccolini, Joseph; Boher, Jean-Marie

Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency

二氢嘧啶脱氢酶缺乏症检测中,分析前处理过程对血浆尿嘧啶的定量影响

Maillard, Maud; Launay, Manon; Royer, Bernard; Guitton, Jérôme; Gautier-Veyret, Elodie; Broutin, Sophie; Tron, Camille; Le Louedec, Félicien; Ciccolini, Joseph; Richard, Damien; Alarcan, Hugo; Haufroid, Vincent; Tafzi, Naïma; Schmitt, Antonin; Etienne-Grimaldi, Marie-Christine; Narjoz, Céline; Thomas, Fabienne